Invasive fungal infections occur in 5-59% of solid organ transplant recipients. Among fungal infections, Cryptococcus remains a significant opportunistic infection in solid organ transplant recipients. The incidence of cryptococcal infection in solid organ recipients was about 2.8 per 100 transplant recipients. Mortality rates in organ transplant recipients with cryptococcosis range from 15% to 20%.The type of primary immunosuppressive agents used in solid organ transplant recipients influences the predominant clinical manifestations of cryptococcosis. Patients who are receiving tacrolimus were significantly less likely to have central nervous system involvement and more likely to have skin, soft tissue and osteoarticular involvement than patients receiving non tacrolimus-based immunosuppressive agents We report a case of cutaneous Cryptococcus neoformans infection in 59 years old renal transplant recipient who underwent renal transplantation ten years ago. He was on immunosuppressant drugs like tacrolimus. High clinical suspicion will help in early diagnosis and treatment. J Microbiol Infect Dis 2019; 9(4): 164-166. 
INTRODUCTION
Invasive fungal infections have been reported in 5 to 59% of organ transplant recipients. Approximately 8% of invasive fungal infections in solid organ transplant recipients are due to cryptococcosis and is the third most common invasive fungal infection after candida and Aspergillus. Cryptococcosis has been commonly encountered in HIV-infected patients. There are reports of cryptococcosis in non-HIV-infected patients such as human stem cell transplant recipients, solid organ transplant recipients, patients with haematologic malignancies and patients with other malignancies. Approximately 20-60% of cryptococcosis in HIV negative patients occurs in solid organ transplant recipients [1] . In an Indian study, 6.1% of renal transplant recipients were affected by systemic fungal infections. Cryptococcosis was generally a late infectious complication in renal transplant recipients. Cutaneous Cryptococcosis is a manifestation of disseminated infection. CD4+ T-helper responses are critical mediators of immunity against Cryptococcus. Cells of Th1 and Th17 lineage confer protection, T-regulatory cells and Th2 responses compromise host resistance and facilitate disease progression [2] . The cumulative effect of pathogen-induced immunosuppression, withdrawal of immunosuppression and administration of effective antifungal therapy is associated with a shift in the host immune repertoire towards physiologic inflammatory responses that can lead to immune reconstitution syndrome (IRS) [3] .
CASE
A 59-year-old patient admitted to our hospital with complaints of reddish discolouration of right thigh and left calf regions associated with pain and fever of 2 weeks duration. He underwent kidney transplantation 10 years ago. Since then he was on tacrolimus (calcineurin inhibitor) and other Immunosuppressant drugs to prevent Investigations showed WBC: 10,500/cumm, random blood sugar: 202 mg/dl, serum creatinine: 3.14/dl, urea: 133mg/dl, K: 4.8 mEq/L. 2D Echo and tee transesophageal echo showed 0.5 cm 2 mobile mass on aortic valve (suspicious vegetation). Urine and blood cultures did not show any growth. Patient underwent incision and drainage and the pus was sent for microbiological analysis like gram stain, AFB stain, bacterial culture and TB culture. AFB culture did not show any growth of mycobacterium. Gram stain of the pus showed spherical budding yeast cells with halo around the yeast cell [ Figure 1 ]. India Ink staining from the sample showed budding yeast cells with a capsule around them. Pus was inoculated on Sabouraud dextrose agar (SDA), Mac Conkey agar and Blood agar. After 48 hrs of incubation, culture showed creamy flat, shiny, moist colonies with smooth edge and was identified as Cryptococcus neoformans [ Figure  2 ]. Cryptococcal antigen titre in the blood was 1:32. Initially he was put on fluconazole, but he did not show any clinical improvement. Tacrolimus was stopped and antifungal agent was upgraded to lipososomal amphotericin B. Haemodialysis was started in view of worsening renal parameters. Gradually he improved with amphotericin B and discharged with same treatment. He was followed up on outpatient basis. Figure 2 . Creamy moist colonies on SDA.
DISCUSSION

Fungal
infections following solid-organ transplantation is a major cause of morbidity and mortality. Cryptococcus neoformans is present in soils enriched by bird excreta, fruits etc. Cutaneous cryptococcal infection may present as erythematous swellings, firm nodules and pustules. The skin is the most common affected site in solid organ transplant recipients who are receiving calcineurin inhibitor like tachrolimus with an incidence of 67% and 17% of patients will have meningitis. Calcineurin inhibitors don't appear to influence the incidence but may affect the extent of cryptococcal infection [4] . Cryptococcosis in solid organ transplant recipients is typically a late infectious complication. The median time of onset is 16-21months after transplantation [5] . In our case, the patient came to our hospital with bilateral lower limb cellulitis 10 years after kidney transplantation.
Temperature-dependent inhibition of Cryptococcus by tacrolimus may prevent CNS infection but allow the growth of the fungus at cooler body sites such as skin. soft tissue etc. [6] . Our patient who is receiving tacrolimus as an immunosuppressive agent had cutaneous lesions in the lower extremities.
Discontinuation of calcineurin inhibitors was associated with five-fold increased risk of inflammatory reconstitution syndrome (IRS) in transplant recipients with cryptococcal infection. In our case, patient developed renal dysfunction after discontinuation of immunosuppressant drugs and continuation of antifungal therapy. 
